Fulgent Genetics (FLGT) EBIT Growth (5y) (2020 - 2026)
Powered by 
Analysis
Fulgent Genetics (FLGT) EBIT Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.78% |
| Mar 31, 2026 | -16.32% |
| Dec 31, 2025 | -14.90% |
| Sep 30, 2025 | -17.52% |
| Jun 30, 2025 | -56.76% |
| Mar 31, 2025 | -59.56% |
| Dec 31, 2024 | -108.55% |
| Sep 30, 2024 | -67.84% |
| Jun 30, 2024 | -131.22% |
| Mar 31, 2024 | -64.26% |
| Dec 31, 2023 | -171.26% |
| Sep 30, 2023 | 17.64% |
| Jun 30, 2023 | -81.65% |
| Mar 31, 2023 | -62.45% |
| Dec 31, 2022 | -77.58% |
| Sep 30, 2022 | 17.48% |
| Jun 30, 2022 | 144.45% |
| Mar 31, 2022 | 291.70% |
| Dec 31, 2021 | 160.44% |
| Sep 30, 2021 | 197.02% |